3rd Quarter - Report
FOLEY HOAG LLP for CHIMERIX, INC.
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Congressional outreach regarding biodefense medical countermeasures for smallpox. Reauthorization of the Pandemic and All-Hazards Preparedness Act (H.R. 2405 and S. 1855). FY2013 HHS/BARDA funding (Senate Labor-HHS Appropriations and House Labor-HHS Appropriations). Biomedical Advanced Research and Development Authority (BARDA)
| Lobbyist | Covered position, as disclosed |
|---|---|
| J KEVIN BRENNAN New | — |
| PAUL KIM | — |
| DAYLE LEWIS CRISTINZIO | Sen Harry Reid, Leg Dir; Rep Steny Hoyer, Sr Leg, Asst; Sen Charles Schumer, Dir Econ Dev&Approp |
| NICK LITTLEFIELD | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.